Skip to main content

Published locations for A randomized phase III trial of BIBW 2992 versus chemotherapy as first-line treatment for stage IIIB/IV adenocarcinoma of the lung harboring an epidermal growth factor receptor-activating mutation

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. A randomized phase III trial of BIBW 2992 versus chemotherapy as first-line treatment for stage IIIB/IV adenocarcinoma of the lung harboring an epidermal growth factor receptor-activating mutation

User login

  • Reset your password
  • /content/randomized-phase-iii-trial-bibw-2992-versus-chemotherapy-first-line-treatment-stage-iiib/iv
  • /jcso/article/35293/randomized-phase-iii-trial-bibw-2992-versus-chemotherapy-first-line-treatment
  • /oncologypractice/article/35293/randomized-phase-iii-trial-bibw-2992-versus-chemotherapy-first-line
  • /hematology-oncology/article/35293/randomized-phase-iii-trial-bibw-2992-versus-chemotherapy-first